Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
348 participants
INTERVENTIONAL
2008-07-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Blood Pressure in Colorado
NCT00520988
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
NCT00781365
Electronic Communications and Home Blood Pressure Monitoring
NCT00158639
Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure
NCT05180045
Team-Based Home Blood Pressure Monitoring
NCT05488795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary:
• To determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines
Secondary:
The following parameters will be evaluated between groups:
* Change in BP measures between baseline and at 6 months
* Proportion of patients who are receiving antihypertensive treatments in accordance to national clinical practice guidelines
* Adherence to hypertensive medication regimen during the 6-month follow-up period
* Patient satisfaction with the care model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
The control group receiving usual care
No interventions assigned to this group
Home Blood Pressure Monitoring Group
Intervention group
Home Blood Pressure Monitoring
Home blood pressure readings are taken at least 3 times a week, uploaded to a Microsoft Health Vault account through American Heart Association Heart360 at least 1 time per week. Patients are followed by a clinical pharmacist, with physician oversight, who will make adjustments to antihypertensive medications or suggest additional medications using national JNC VII and KPCO hypertension guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home Blood Pressure Monitoring
Home blood pressure readings are taken at least 3 times a week, uploaded to a Microsoft Health Vault account through American Heart Association Heart360 at least 1 time per week. Patients are followed by a clinical pharmacist, with physician oversight, who will make adjustments to antihypertensive medications or suggest additional medications using national JNC VII and KPCO hypertension guidelines.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive primary care from one of the participating clinics,
* The two most recent BPs documented within that last 24 months are elevated (SBP\>140 and/or DBP\>90)
* Receiving \< 3 antihypertensive medications, and
* Have access to a computer with a USB port.
Exclusion Criteria
* Patients on dialysis or being followed by nephrology,
* Patients with coronary artery disease, given these patients are already followed by the Clinical Pharmacy Cardiac Risk Service (CPCRS),
* On KPCO "Do Not Call" or deceased list,
* PCP does not give permission to include patient in the study,
* BP is at or below target at the baseline study visit,
* Not English-speaking.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David J Magid, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente
Kari Olson, PharmD
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente
Sarah J Billups, PharmD
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Colorado, Institute of Health Research
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):157-63. doi: 10.1161/CIRCOUTCOMES.112.968172. Epub 2013 Mar 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CO-08DMagi-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.